I-Kappa B Kinase

Image Results

Recent Publications on I-Kappa B Kinase:
KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. BACKGROUND: Increasing the efficacy of chemotherapeutics by reducing...	27th June, 2008	Department of Dermatology and Venereology, University Medical Center	J Natl Cancer Inst. 2008 Jun 18;100(12):862-75. Epub 2008 Jun 10. DOI Direct Link
Resolving "kinks" of chemotherapy in melanoma. BACKGROUND: Increasing the efficacy of chemotherapeutics by reducing...	27th June, 2008		J Natl Cancer Inst. 2008 Jun 18;100(12):833-5. Epub 2008 Jun 10. DOI Direct Link
Sorting out the p63 signaling network. p63 is a transcription factor required for normal epidermal development...	25th June, 2008	Department of Dermatology and Charles C. Gates Regenerative Medicine and	J Invest Dermatol. 2008 Jul;128(7):1617-9. DOI Direct Link
17-Acetoxyjolkinolide B irreversibly inhibits I{kappa}B kinase and induces apoptosis of tumor cells. Nuclear factor-kappaB (NF-kappaB) is critically important for tumor cell...	21st June, 2008	Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555	Mol Cancer Ther. 2008 Jun;7(6):1523-32. DOI Direct Link
Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation. NF-kappaB plays an important role in oncogenesis. Recently, we have...	21st June, 2008	Department of Molecular Oncology, Institute of Gerontology, Nippon Medical	Biochem Biophys Res Commun. 2008 Jul 18;372(1):137-41. Epub 2008 May 12. DOI Direct Link
→View more research publications.

BioNews Results for I-Kappa B Kinase:
Acute Pancreatitis: Research on acute pancreatitis detailed by I. Samuel and co-authors	NewsRX: Jun 20 2008 11:22PM Matching: kappa b kinase

I-Kappa B Kinase Patents:
US Patent No.	Title
7196105	Treatment of human multiple myeloma by curcumin
7105576	Synergistic effects of nuclear transcription factor NF-.kappa.B inhibitors and anti-neoplastic agents
6723830	Short peptides which selectively modulate the activity of protein kinases

BioPortfolio Ltd. offers e-mail and postal lists for I-Kappa B Kinase scientists - we have details of around 189 individuals working on I-Kappa B Kinase .

This page has been viewed 69 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for I-Kappa B Kinase across BioPortfolio, or bestselling I-Kappa B Kinase books or recently published I-Kappa B Kinase books .

Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.

I-Kappa B Kinase

Image Results

Recent Publications on I-Kappa B Kinase:

BioNews Results for I-Kappa B Kinase:

I-Kappa B Kinase Patents: